Envoy Medical (COCH) Competitors $1.29 -0.04 (-3.01%) Closing price 09/12/2025 04:00 PM EasternExtended Trading$1.30 +0.01 (+0.78%) As of 09/12/2025 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock COCH vs. RCEL, OBIO, SPAI, NSPR, EDAP, ZJYL, FONR, HYPR, BDMD, and APYXShould you be buying Envoy Medical stock or one of its competitors? The main competitors of Envoy Medical include Avita Medical (RCEL), Orchestra BioMed (OBIO), Safe Pro Group (SPAI), InspireMD (NSPR), EDAP TMS (EDAP), Jin Medical International (ZJYL), Fonar (FONR), Hyperfine (HYPR), Baird Medical Investment (BDMD), and Apyx Medical (APYX). These companies are all part of the "medical equipment" industry. Envoy Medical vs. Its Competitors Avita Medical Orchestra BioMed Safe Pro Group InspireMD EDAP TMS Jin Medical International Fonar Hyperfine Baird Medical Investment Apyx Medical Envoy Medical (NASDAQ:COCH) and Avita Medical (NASDAQ:RCEL) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their media sentiment, dividends, profitability, valuation, institutional ownership, risk, earnings and analyst recommendations. Do analysts rate COCH or RCEL? Envoy Medical presently has a consensus target price of $9.25, suggesting a potential upside of 617.05%. Avita Medical has a consensus target price of $11.60, suggesting a potential upside of 154.39%. Given Envoy Medical's stronger consensus rating and higher possible upside, equities analysts clearly believe Envoy Medical is more favorable than Avita Medical.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Envoy Medical 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00Avita Medical 1 Sell rating(s) 1 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.40 Do insiders & institutionals have more ownership in COCH or RCEL? 8.6% of Envoy Medical shares are held by institutional investors. Comparatively, 27.7% of Avita Medical shares are held by institutional investors. 58.9% of Envoy Medical shares are held by company insiders. Comparatively, 2.8% of Avita Medical shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth. Which has more risk and volatility, COCH or RCEL? Envoy Medical has a beta of 2.19, suggesting that its stock price is 119% more volatile than the S&P 500. Comparatively, Avita Medical has a beta of 1.58, suggesting that its stock price is 58% more volatile than the S&P 500. Does the media favor COCH or RCEL? In the previous week, Avita Medical had 4 more articles in the media than Envoy Medical. MarketBeat recorded 7 mentions for Avita Medical and 3 mentions for Envoy Medical. Avita Medical's average media sentiment score of 0.46 beat Envoy Medical's score of 0.15 indicating that Avita Medical is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Envoy Medical 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Avita Medical 1 Very Positive mention(s) 1 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Which has higher valuation and earnings, COCH or RCEL? Envoy Medical has higher earnings, but lower revenue than Avita Medical. Avita Medical is trading at a lower price-to-earnings ratio than Envoy Medical, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioEnvoy Medical$222K125.05-$20.80M-$1.43-0.90Avita Medical$74.88M1.62-$61.85M-$1.97-2.31 Is COCH or RCEL more profitable? Avita Medical has a net margin of -68.87% compared to Envoy Medical's net margin of -10,961.26%. Envoy Medical's return on equity of 0.00% beat Avita Medical's return on equity.Company Net Margins Return on Equity Return on Assets Envoy Medical-10,961.26% N/A -236.14% Avita Medical -68.87%-632.62%-71.52% SummaryEnvoy Medical beats Avita Medical on 9 of the 16 factors compared between the two stocks. Get Envoy Medical News Delivered to You Automatically Sign up to receive the latest news and ratings for COCH and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding COCH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart COCH vs. The Competition Export to ExcelMetricEnvoy MedicalMED INSTRUMENTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$28.62M$6.95B$5.87B$10.14BDividend YieldN/A1.21%5.68%4.59%P/E Ratio-0.9025.5274.5225.93Price / Sales125.05192.52549.78198.13Price / CashN/A22.1337.5660.44Price / Book-1.475.0012.166.29Net Income-$20.80M$176.38M$3.28B$270.77M7 Day Performance-2.27%1.00%0.87%3.88%1 Month Performance-12.84%0.74%4.96%4.88%1 Year Performance-60.50%10.34%60.74%26.01% Envoy Medical Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)COCHEnvoy Medical2.0902 of 5 stars$1.29-3.0%$9.25+617.1%-61.5%$28.62M$222K-0.9034Short Interest ↑Gap DownRCELAvita Medical2.4607 of 5 stars$4.19-0.5%$11.60+176.8%-53.0%$112.07M$64.25M-2.13130OBIOOrchestra BioMed3.0886 of 5 stars$2.71-0.7%$13.50+398.2%-55.5%$105.50M$2.64M-1.484Short Interest ↑SPAISafe Pro Group3.3254 of 5 stars$7.49+16.3%$10.50+40.2%+183.9%$104.12M$2.17M-9.3611Trending NewsAnalyst ForecastAnalyst RevisionNSPRInspireMD3.625 of 5 stars$2.46+2.5%$4.50+82.9%-11.9%$102.63M$7.07M-3.2850Short Interest ↓EDAPEDAP TMS2.2427 of 5 stars$2.80+2.2%$8.50+203.6%-23.7%$102.45M$69.18M-4.59230Short Interest ↑ZJYLJin Medical InternationalN/A$0.65+3.6%N/A-75.1%$98.66M$23.50M0.00245Short Interest ↑FONRFonar1.1923 of 5 stars$15.58-0.1%N/A-5.2%$96.77M$102.88M12.46480News CoverageHigh Trading VolumeHYPRHyperfine1.3422 of 5 stars$1.27+6.7%$1.28+1.0%+42.0%$93.51M$12.89M-2.44190BDMDBaird Medical InvestmentN/A$2.44-1.2%N/AN/A$88.25MN/A0.00N/APositive NewsAPYXApyx Medical2.4742 of 5 stars$2.06flatN/A+69.4%$77.91M$48.10M-4.58270Short Interest ↓ Related Companies and Tools Related Companies Avita Medical Competitors Orchestra BioMed Competitors Safe Pro Group Competitors InspireMD Competitors EDAP TMS Competitors Jin Medical International Competitors Fonar Competitors Hyperfine Competitors Baird Medical Investment Competitors Apyx Medical Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:COCH) was last updated on 9/13/2025 by MarketBeat.com Staff From Our PartnersHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredWhy Trump’s “Smart Dollar” could rewrite the rulesMUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | SponsoredRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredNvidia Times 1,000,000Nvidia’s latest AI chip is a $25,000 powerhouse — with 80 billion transistors and the ability to perform 60 tr...Paradigm Press | Sponsored“Sell Nvidia before earnings”Eric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has bee...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Envoy Medical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Envoy Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.